Perigon Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Buy
15,776
+499
+3% +$178K 0.1% 196
2025
Q4
$5M Sell
15,277
-1,060
-6% -$336K 0.09% 208
2025
Q3
$4.61M Buy
16,337
+708
+5% +$205K 0.09% 208
2025
Q2
$4.36M Buy
15,629
+274
+2% +$77.6K 0.1% 197
2025
Q1
$4.78M Sell
15,355
-790
-5% -$233K 0.12% 167
2024
Q4
$4.35M Buy
16,145
+3,236
+25% +$960K 0.11% 180
2024
Q3
$4.16M Buy
12,909
+173
+1% +$56.6K 0.11% 172
2024
Q2
$3.98M Buy
12,736
+540
+4% +$159K 0.12% 164
2024
Q1
$3.47M Buy
12,196
+275
+2% +$80.5K 0.11% 176
2023
Q4
$3.43M Buy
11,921
+25
+0.2% +$6.81K 0.11% 164
2023
Q3
$3.2M Sell
11,896
-308
-3% -$76.9K 0.13% 155
2023
Q2
$2.71M Buy
12,204
+1,650
+16% +$383K 0.11% 175
2023
Q1
$2.55M Buy
10,554
+360
+4% +$88.4K 0.15% 152
2022
Q4
$2.68M Buy
10,194
+1,959
+24% +$525K 0.17% 137
2022
Q3
$1.86M Buy
8,235
+243
+3% +$58.9K 0.16% 128
2022
Q2
$1.95M Buy
7,992
+355
+5% +$87K 0.16% 129
2022
Q1
$1.85M Buy
7,637
+489
+7% +$112K 0.13% 142
2021
Q4
$1.61M Sell
7,148
-170
-2% -$35.9K 0.12% 156
2021
Q3
$1.56M Sell
7,318
-933
-11% -$215K 0.14% 141
2021
Q2
$2.01M Buy
8,251
+33
+0.4% +$8.12K 0.18% 110
2021
Q1
$2.04M Buy
8,218
+910
+12% +$217K 0.21% 98
2020
Q4
$1.68M Buy
7,308
+4,150
+131% +$957K 0.2% 92
2020
Q3
$803K Buy
3,158
+456
+17% +$113K 0.11% 147
2020
Q2
$637K Buy
2,702
+482
+22% +$110K 0.1% 160
2020
Q1
$484K Buy
2,220
+751
+51% +$164K 0.09% 171
2019
Q4
$353K Buy
1,469
+139
+10% +$30.6K 0.07% 176
2019
Q3
$272K Sell
1,330
-753
-36% -$145K 0.06% 181
2019
Q2
$384K Buy
2,083
+80
+4% +$14.3K 0.09% 149
2019
Q1
$362K Buy
2,003
+20
+1% +$3.82K 0.08% 151
2018
Q4
$394K Sell
1,983
-1,306
-40% -$255K 0.1% 140
2018
Q3
$682K Sell
3,289
-1,907
-37% -$376K 0.17% 103
2018
Q2
$959K Buy
5,196
+2,705
+109% +$478K 0.29% 75
2018
Q1
$425K Buy
2,491
+1,894
+317% +$348K 0.16% 94
2017
Q4
$104K Hold
597
0.04% 194
2017
Q3
$111K Sell
597
-26,430
-98% -$4.68M 0.04% 251
2017
Q2
$4.66M Hold
27,027
1.01% 24
2017
Q1
$4.43M Hold
27,027
0.94% 28
2016
Q4
$4.9M Sell
27,027
-259
-0.9% -$39K 1.07% 22
2016
Q3
$4.55M Buy
+27,286
New +$4.61M 1.17% 21
2016
Q2
Sell
-26,689
Closed -$4M 442
2016
Q1
$4M Hold
26,689
1.25% 20
2015
Q4
$4.33M Buy
26,689
+1,000
+4% +$157K 1.2% 18
2015
Q3
$3.55M Sell
25,689
-152
-0.6% -$24K 1.05% 17
2015
Q2
$3.97M Buy
25,841
+133
+0.5% +$21.3K 1.04% 16
2015
Q1
$4.11M Hold
25,708
1.13% 15
2014
Q4
$4.09M Sell
25,708
-25,030
-49% -$3.9M 1.23% 13
2014
Q3
$7.13M Sell
50,738
-4
-0% -$522 2.12% 6
2014
Q2
$6.01M Buy
50,742
+48,850
+2,582% +$5.65M 1.71% 7
2014
Q1
$233K Sell
1,892
-67
-3% -$8.13K 0.13% 121
2013
Q4
$223K Buy
+1,959
New +$223K 0.12% 123

Other funds holding AMGN

Perigon Wealth Management's AMGN Position: Q1 2026 in Review

Perigon Wealth Management increased its Amgen (AMGN) stake by 3.3% in Q1 2026, buying an estimated $178K and bringing the position to 15,776 shares worth $5.55M. The position accounts for 0.1% of the portfolio, ranked #196.

Perigon Wealth Management first reported a position in AMGN in Q4 2013 and has held it in 49 quarters since. The position peaked at $7.13M in Q3 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Perigon Wealth Management held 15,776 shares of Amgen worth $5.55M as of Q1 2026.
  • Perigon Wealth Management bought 499 Amgen shares in Q1 2026, an estimated $178K.
  • Amgen made up 0.1% of Perigon Wealth Management's portfolio in Q1 2026, its #196 holding.
  • Perigon Wealth Management first reported a position in Amgen in Q4 2013 and has held it in 49 quarters since.
  • Perigon Wealth Management's Amgen position peaked at $7.13M in Q3 2014.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.